U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06921551) titled 'Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis' on March 27.
Brief Summary: The goal of this study is to explore the potential clinical benefits of the ABLE Exoskeleton as part of a rehabilitation program in people with multiple sclerosis. The main question it aims to answer is:
Can a rehabiliation program with the ABLE Exoskeleton help to mantain the physical and psychosocial health of people with multiple sclerosis?
Participants will:
* Have a gait training session of 60 min with the exoskeleton once a week for 12 months at the clinic
* Have an evaluation (tests and questionnaires) ...